Albutec
Rostock, DE · 1 known investors
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.
Founders & leadership
KS
Katrin StangeChief Executive Officer
JS
Jan StangeChief Medical Officer
Investors · 1
Frequently asked questions
- What does Albutec do?
- Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.
- Who are Albutec's investors?
- Albutec's investors include Fresenius Medical Care Ventures.
- Where is Albutec headquartered?
- Albutec is headquartered in Rostock, DE.